Skip to main content

Variable cost of a Greek ICU

Introduction

The ICU consumes almost 20% of total hospital resources, despite accounting for less than 10% of hospital beds. Medical cost can be divided into a fixed part, consisting of personnel and accommodation expenses, and a variable part, determined by the needs of each patient (medications, consumables, examinations). In order to rationalize medical cost, estimation of expenses must be real and individualized. The aim of this study was to assess the variable cost of critically ill patients in a new, seven-bed, adult, general ICU, using bottom-up costing methodology.

Methods

All 138 patients who were treated during 2011, and stayed for at least 24 hours, were included in the study. Data were retrospectively collected from patient records and included demographics, cause of admission, APACHE II score at admission, length of stay (LOS) and outcome. Cost was recorded for every day and for every patient, based on a hospital-specific cost catalogue and on national agreements. Data are presented as mean ± SEM. Analysis of data was carried out using Graph Pad Prism 5.0., applying Student's t test.

Results

The age of participants (84 men and 54 women, 71 medical and 67 surgical) was 68.75 ± 1.18, APACHE II score was 18.64 ± 0.61, LOS was 18.46 ± 2.54, and mortality was 19%. The majority of the patients (61%) were mechanically ventilated. The total days of ICU stay were 2,548 and the total variable cost was €1,460,465 (€573.18 per patient and per days). Cost per patient was subdivided as follows: medication (including drugs, fluids, blood products, nutrition): 56.49%, examinations (including laboratory, microbiological assays and diagnostic procedures): 22.23%, consumables: 21.26%. As for medication cost, the largest part was comprised of antibiotics (45.69%), followed by blood products (17.61%) and cardiovascular drugs (12.39%). Costs for medical patients were significantly higher than those for surgical patients (P 0.0001).

Conclusion

The total average cost per patient and per days was found to be € 573.18. Medication expenditure was responsible for the highest variable cost of intensive care treatment. Among drugs, antibiotics accounted for the largest part. A medical cause of admission was correlated with higher costs.

References

  1. 1.

    McLaughlin AM, et al.: Intensive Care Med. 2009, 35: 2135-2140. 10.1007/s00134-009-1622-1

    Article  PubMed  Google Scholar 

  2. 2.

    Rossi C, et al.: Intensive Care Med. 2006, 32: 545-552. 10.1007/s00134-006-0080-2

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to E Tsigou.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Tsigou, E., Karabatsou, D., Boutzouka, E. et al. Variable cost of a Greek ICU. Crit Care 17, P485 (2013). https://doi.org/10.1186/cc12423

Download citation

Keywords

  • Blood Product
  • Variable Cost
  • Medication Expenditure
  • Cardiovascular Drug
  • Variable Part